Literature DB >> 6437301

Efficacy of ivermectin against the mange mite Sarcoptes scabiei var suis in pigs.

R Alva-Valdes, D H Wallace, G W Benz, A G Foster, J E Holste.   

Abstract

The efficacy of ivermectin administered by esophageal intubation in a single dose was evaluated against the mange mite Sarcoptes scabiei var suis in 24 naturally infested pigs. Six pigs were allocated to each of the 4 treatment groups. Control (group 1) pigs were given nonmedicated water, group 2 were given ivermectin at 300 micrograms/kg of body weight, group 3 were given ivermectin at 400 micrograms/kg, and group 4 were given ivermectin at 500 micrograms/kg. The pigs were examined for S scabiei before treatment and on days 7, 14, 21, and 28 after treatment. Of the 18 ivermectin-treated pigs, 10 had no live S scabiei recovered on day 7 after treatment, 16 had none on day 14, 18 had none on day 21, and 16 had none on day 28. All 6 nonmedicated control pigs had live S scabiei recovered on days 7 and 21, and 5 control pigs had mites on days 14 and 28. The single administration of ivermectin given by esophageal intubation was highly effective in reducing the number of S scabiei at all dose levels tested. The pooled ivermectin-treated groups had significantly (P less than 0.01) fewer mites than the control group on all posttreatment examination days. There were no statistically significant differences among the ivermectin dose levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6437301

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  Determination of ivermectin in medicated feeds by liquid chromatography with fluorescence detection.

Authors:  Konrad Pietruk; Piotr Jedziniak
Journal:  ScientificWorldJournal       Date:  2013-12-19

2.  Elimination of mange mites Sarcoptes scabiei var. suis from two naturally infested Danish sow herds using a single injection regime with doramectin.

Authors:  J C E Jensen; L H Nielsen; T Arnason; V Cracknell
Journal:  Acta Vet Scand       Date:  2002       Impact factor: 1.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.